Multidetector computed tomography angiography prior to bronchial artery embolization helps detect culprit ectopic bronchial arteries and non-bronchial systemic arteries originating from subclavian and internal mammary arteries and improve hemoptysis-free early survival rate in patients with hemoptysis

2018 ◽  
Vol 29 (4) ◽  
pp. 1950-1958 ◽  
Author(s):  
Pei-Jun Li ◽  
He Yu ◽  
Ye Wang ◽  
Fa-Ming Jiang ◽  
Wei Wang ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Survival Rate ◽  
Bronchial Artery ◽  
Bronchial Artery Embolization ◽  
Artery Embolization ◽  
Bronchial Arteries ◽  
Mammary Arteries ◽  
Internal Mammary ◽  
Systemic Arteries ◽  
Multidetector Computed Tomography Angiography

scholarly journals Value of multidetector computed tomography angiography before bronchial artery embolization in hemoptysis management and early recurrence prediction: a prospective study

2020 ◽  
Author(s):  
Huu Y Le ◽  
Van Nam Le ◽  
Ngoc Hung Pham ◽  
Anh Tuan Phung ◽  
Thanh Tung Nguyen ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Multidetector Computed Tomography ◽  
Recurrence Rate ◽  
Bronchial Artery ◽  
Clinical Success ◽  
Early Recurrence ◽  
Bronchial Artery Embolization ◽  
Mdct Angiography ◽  
Artery Embolization ◽  
Bronchial Arteries

Abstract Background To prospective evaluate the role and clinical efficacy of multidetector computed tomography (MDCT) angiography before bronchial artery embolization (BAE) for the management of hemoptysis, and to investigate the predictors of early recurrence.Methods From August 2019 to July 2020, a double-center study of 57 patients with hemoptysis referred for BAE underwent MDCT angiography before. A prospective analysis of culprit arteries detected by MDCT angiography allowed evaluation of the role of this technique. Follow-up was done for assessment of the efficacy of BAE with preprocedural MDCT angiography and to explore the risk factors of early recurrent hemoptysis.Results The accuracy of MDCT angiography in the identification of culprit arteries was as high as 97.5%. The average number of total culprit arteries per patient was 2.75 \(\pm\) 1.73, among them the average number of culprit ectopic bronchial arteries (BAs) and non-bronchial systemic arteries (NBSAs) per patient were 0.21 \(\pm\) 0.41 and 1.04 \(\pm\) 1.57, respectively. The immediate clinical success, total hemoptysis recurrence rate, and early hemoptysis recurrence rate of BAE following MDCT angiography were 94.7%, 18.5%, 16.7%, respectively. Aspergilloma (HR 6.63, 95% CI 1.31–33.60, p = 0.022) was associated with an increase in the risk of early recurrence.Conclusions MDCT angiography should be performed before BAE for the management of hemoptysis. Aspergilloma was an independent predictor for early recurrence.

Clinical Impact of Multidetector Row Computed Tomography before Bronchial Artery Embolization in Patients with Hemoptysis: A Prospective Study

2013 ◽  
Vol 64 (1) ◽  
pp. 61-73 ◽  
Author(s):  
Mudit Gupta ◽  
Deep Narayan Srivastava ◽  
Ashu Seith ◽  
Sanjay Sharma ◽  
Sanjay Thulkar ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Bronchial Artery ◽  
Maximum Intensity Projection ◽  
Multidetector Row Computed Tomography ◽  
Bronchial Artery Embolization ◽  
Artery Embolization ◽  
Multidetector Row ◽  
Dimensional Reconstruction ◽  
A Prospective Study ◽  
Systemic Arteries

Purpose To evaluate prospectively the role and impact of multidetector row computed tomography (MDCT) before bronchial artery embolization (BAE) in patients with hemoptysis. Methods MDCT of the thorax was performed in 27 patients (21 men, 6 women; age range, 22-70 years; mean, 39 years) with hemoptysis who were referred for BAE. Transverse, multiplanar reconstruction, and 3-dimensional reconstruction (maximum intensity projection and volume rendered) images were analysed to identify the abnormal hypertrophied bronchial and nonbronchial systemic arteries causing hemoptysis, their origin and course were noted. Digital subtraction angiography was performed with the knowledge of findings of MDCT. Selective arteriogram of abnormal bronchial as well as nonbronchial arteries was performed. Embolization was attempted in 25 of these patients (92.6%) by using polyvinyl alcohol particles (350-500 μm), Gelfoam or Embospheres (400-700 μm). Follow-up was done for a mean period of 20.5 months. Results Based on MDCT, 2 of 27 patients were found unsuitable for BAE. On computed tomography, 38 arteries (27 bronchial and 11 nonbronchial systemic arteries) were identified as abnormal hypertrophied vessels. On angiography, 34 of these arteries (25 bronchial and 9 nonbronchial systemic arteries) were found to be responsible for hemoptysis. Three of these arteries could not be evaluated during angiography, and 1 artery that was identified as abnormal on computed tomography was found normal on angiography. All 25 bronchial and 9 nonbronchial systemic arteries that cause hemoptysis were detected at MDCT. Embolization was successful in 23 of 25 patients. Conclusion MDCT enables detection and depiction of all bronchial and nonbronchial systemic arteries causing hemoptysis.

Control of Tubercular Haemoptysis by Bronchial Artery Embolization

1997 ◽  
Vol 27 (3) ◽  
pp. 149-150 ◽  
Author(s):  
Sanjeev Mani ◽  
Rajesh Mayekar ◽  
Ravi Rananavare ◽  
Deepti Maniar ◽  
J Mathews Joseph ◽  
...  
Keyword(s):  
Bronchial Artery ◽  
Bronchial Artery Embolization ◽  
Artery Embolization ◽  
Selective Embolization ◽  
Bronchial Arteries ◽  
Bleeding Vessel ◽  
Life Threatening ◽  
Abnormal Bleeding ◽  
Recurrent Haemoptysis

Thirty-seven patients presenting with massive or recurrent haemoptysis secondary to tuberculous aetiology were subjected to bronchial artery angiography. Of these, failure to catheterize the bleeding vessel occurred in two patients while embolization was withheld in two patients due to the presence of anterior spinal artery arising from a common intercosto-bronchial trunk. Immediate arrest of bleeding was performed in the remaining 33 patients by selective embolization of the abnormal bronchial arteries with a resorbable material (Gelfoam). Regular follow up for a duration of 6 months after the procedure revealed relapse of haemoptysis in four patients; three were treated by re-embolization of the abnormal bleeding vessels while one patient died due to aspiration immediately on admission. No recurrence of bleeding was seen in the remaining 29 patients. It is concluded that bronchial artery embolization is an effective treatment for immediate control of life-threatening haemoptysis.

scholarly journals Value of multidetector computed tomography angiography before bronchial artery embolization in hemoptysis management and early recurrence prediction: a prospective study

2020 ◽  
Author(s):  
Huu Y Le ◽  
Van Nam Le ◽  
Ngoc Hung Pham ◽  
Anh Tuan Phung ◽  
Thanh Tung Nguyen ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Multidetector Computed Tomography ◽  
Recurrence Rate ◽  
Bronchial Artery ◽  
Clinical Success ◽  
Clinical Success Rate ◽  
Early Recurrence ◽  
Bronchial Artery Embolization ◽  
Mdct Angiography ◽  
Artery Embolization

Abstract Background: Multidetector computed tomography (MDCT) angiography is an useful examination to detect the source of the bleeding in patients with hemoptysis. The aim of the study was to prospectively evaluate the role and clinical efficacy of MDCT angiography before bronchial artery embolization (BAE) for the management of hemoptysis, and to investigate the predictors of early recurrence.Methods: It is a double-center study which included 57 hemoptysis patients undergoing MDCT angiography prior to BAE from August 2019 to July 2020. A prospective analysis of culprit arteries detected by MDCT angiography allowed an evaluation of the role of this technique. A follow-up was done to assess the efficacy of BAE with preprocedural MDCT angiography and to explore the risk factors of early recurrent hemoptysis.Results: The accuracy of MDCT angiography in the identification of culprit arteries was as high as 97.5%. The average number of total culprit arteries per patient was 2.75 1.73. Among which, the average numbers of culprit ectopic bronchial arteries (BAs) and non-bronchial systemic arteries (NBSAs) per patient were 0.21 0.41 and 1.04 1.57, respectively. The immediate clinical success rate, total hemoptysis recurrence rate, and early hemoptysis recurrence rate of BAE following MDCT angiography were 94.7%, 18.5%, 16.7%, respectively. Aspergilloma (HR = 6.63, 95% CI: 1.31-33.60, p = 0.022) was associated with an increase in the risk of early recurrence.Conclusions: MDCT angiography should be performed before BAE for the management of hemoptysis. Aspergilloma was an independent predictor for early recurrence.

scholarly journals Repeat Episodes of Massive Hemoptysis Due to an Anomalous Origin of the Right Bronchial Artery in a Patient with a History of Coccidioidomycosis

2021 ◽  
Vol 23 (3) ◽  
pp. 89-92
Author(s):  
Blerina Asllanaj ◽  
◽  
Elizabeth Benge ◽  
Yi McWhworter ◽  
Sapna Bhatia
Keyword(s):  
Left Subclavian Artery ◽  
Bronchial Artery ◽  
Massive Hemoptysis ◽  
Bronchial Artery Embolization ◽  
Artery Embolization ◽  
Bronchial Arteries ◽  
History Of ◽  
Symptomatic Remission ◽  
The Right ◽  
Right Bronchial Artery

Anomalous bronchial arteries originate outside the space bound by the T5 and T6 vertebrae at the major bronchi. Here, we highlight a case of a 37-year-old man with a past medical history of coccidioidomycosis and who presented with massive hemoptysis. A bronchial angiogram showed the patient had a right bronchial artery originating anomalously from the left subclavian artery. The patient ultimately underwent a bronchial artery embolization, after which he achieved symptomatic remission.

scholarly journals Feasibility and outcomes of bronchial artery embolization in patients with non-massive hemoptysis

2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Jung Han Hwang ◽  
Jeong Ho Kim ◽  
Suyoung Park ◽  
Ki Hyun Lee ◽  
So Hyun Park
Keyword(s):  
Survival Rate ◽  
Bronchial Artery ◽  
Clinical Success ◽  
Massive Hemoptysis ◽  
Recurrent Bleeding ◽  
Recurrence Free Survival ◽  
Bronchial Artery Embolization ◽  
Artery Embolization ◽  
Free Survival

Abstract Purpose To evaluate the safety, efficacy, and long-term outcome of bronchial artery embolization (BAE) in the treatment of non-massive hemoptysis and the prognostic factors associated with recurrent bleeding. Materials and methods From March 2005 to September 2014, BAE was performed in 233 patients with non-massive hemoptysis. All patients had a history of persistent or recurrent hemoptysis despite conservative medical treatment. We assessed the technical and clinical success, recurrence, prognostic factors related to recurrent bleeding, recurrence-free survival rate, additional treatment, and major complications in all the patients. Results Technical success was achieved in 224 patients (96.1%), and clinical success was obtained in 219 (94.0%) of the 233 patients. In addition, 64 patients (27.5%) presented hemoptysis recurrence with median time of 197 days after embolization. Tuberculosis sequelae and presence of aberrant bronchial artery or non-bronchial systemic collaterals were significantly related to recurrent bleeding (p < 0.05). The use of Histoacryl-based embolic materials significantly reduced the recurrent bleeding rate (p < 0.05). Patient who had a tuberculosis sequelae showed a significantly lower recurrence-free survival rate (p = 0.013). Presence of aberrant bronchial artery or non-bronchial systemic collaterals showed a statistically significant correlation with recurrence-free survival rate (p = 0.021). No patients had major complications during follow-up. Conclusions BAE is a safe and effective treatment to manage non-massive hemoptysis. The procedure may offer a better long-term control of recurrent hemoptysis and quality of life than conservative therapy alone.

scholarly journals Embolization for Hemoptysis—Angiographic Anatomy of Bronchial and Systemic Arteries

2018 ◽  
Vol 02 (03) ◽  
pp. 184-190
Author(s):  
Vikash Chennur ◽  
Kumar Shashi ◽  
Stephen Ryan ◽  
Adnan Hadziomerovic ◽  
Ashish Gupta
Keyword(s):  
Bronchial Artery ◽  
Clinical Success ◽  
Massive Hemoptysis ◽  
Bronchial Artery Embolization ◽  
Artery Embolization ◽  
Conventional Angiography ◽  
Pictorial Essay ◽  
Systemic Arteries ◽  
Systemic Arterial Supply ◽  
Arterial Anatomy

AbstractMassive hemoptysis is a potentially fatal respiratory emergency. The majority of these patients are referred to interventional radiology for bronchial artery embolization (BAE). Immediate clinical success in stopping hemoptysis ranges from 70 to 99%. However, recurrent hemoptysis after BAE is seen in 10 to 55% patients. One of the main reasons for recurrence is incomplete embolization due to unidentified aberrant bronchial and/or non-bronchial systemic arterial supply. This pictorial essay aims to describe the normal and variant bronchial arterial anatomy and non-bronchial systemic arterial feeders to the lungs on conventional angiography; the knowledge of which is critical for interventional radiologists involved in the care of patients with hemoptysis.

Sign in / Sign up

Export Citation Format

Share Document